SEC Form 4 · accession 0001104659-16-159835
Aralez Pharmaceuticals Inc. · ARLZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Paul Harris
Director
Period of report
Nov 28, 2016
Accepted (ET)
Nov 30, 2016 · 7:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001660719
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares, without par valueF1,F2 | Nov 28, 2016 | M | 20,000 | $3.92 | A | 614,094 | D | |
| Common Shares, without par valueF3,F4 | Nov 28, 2016 | S | 20,000 | $4.65 | D | 594,094 | D | |
| Common Shares, without par valueF1,F2 | Nov 29, 2016 | M | 104,778 | $3.92 | A | 698,872 | D | |
| Common Shares, without par valueF3,F4,F5 | Nov 29, 2016 | S | 104,778 | $4.9929 | D | 594,094 | D | |
| Common Shares, without par value | holding | — | — | — | 600,188 | I | By spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2,F1,F6 | $3.92 | Nov 28, 2016 | M | 20,000 | D | — | Dec 1, 2016 | Common Shares, without par value | 20,000 | 104,778 | D |
| Employee Stock Option (right to buy)F2,F1,F6 | $3.92 | Nov 29, 2016 | M | 104,778 | D | — | Dec 1, 2016 | Common Shares, without par value | 104,778 | 0 | D |
Explanation of responses
- F1Price is presented in Canadian dollars.
- F2The exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 16, 2016, as amended.
- F3Price is presented in United States dollars.
- F4The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 16, 2016, as amended.
- F5This transaction was executed in multiple trades at prices ranging from $4.76 to $5.10. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6The option was exercisable as of the Reporting Person's previous filing on Form 3, dated as of February 8, 2016.
Remarks
The transactions reported hereby relate to the exercise of employee stock options originally granted to the Reporting Person on December 1, 2011 with a five-year term, and were exercised shortly prior to their scheduled expiration date of December 1, 2016.